These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 7534802

  • 1. Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor.
    Wan XS, Koch CJ, Lord EM, Manzone H, Billings PC, Donahue JJ, Odell CS, Miller JH, Schmidt NA, Kennedy AR.
    J Immunol Methods; 1995 Mar 13; 180(1):117-30. PubMed ID: 7534802
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibodies against soybean Bowman-Birk inhibitor recognize the protease-reactive loops.
    Mao Y, Lai C, Vogtentanz G, Schmidt B, Day T, Miller J, Brandon DL, Chen D.
    Protein J; 2005 Jul 13; 24(5):275-82. PubMed ID: 16284725
    [Abstract] [Full Text] [Related]

  • 3. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR.
    Nutr Cancer; 2002 Jul 13; 43(2):167-73. PubMed ID: 12588697
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents.
    Gladysheva IP, Moroz NA, Karmakova TA, Nemtsova ER, Yakubovskaya RI, Larionova NI.
    J Drug Target; 2001 Jul 13; 9(5):303-16. PubMed ID: 11770701
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA, Paterson Y, Kennedy AR.
    Nutr Cancer; 1994 Jul 13; 22(2):185-93. PubMed ID: 14502847
    [Abstract] [Full Text] [Related]

  • 8. ELISA analysis of soybean trypsin inhibitors in processed foods.
    Brandon DL, Bates AH, Friedman M.
    Adv Exp Med Biol; 1991 Jul 13; 289():321-37. PubMed ID: 1716818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Origins of circular dichroism bands in Bowman-Birk soybean trypsin inhibitor.
    Kay E.
    J Biol Chem; 1976 Jun 10; 251(11):3411-6. PubMed ID: 931992
    [Abstract] [Full Text] [Related]

  • 12. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR.
    Int J Radiat Biol; 2023 Jun 10; 99(6):882-890. PubMed ID: 34325613
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 10; 9(1):43-7. PubMed ID: 10667462
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gastric retention and stability of lipidized Bowman-Birk protease inhibitor in mice.
    Wang J, Shen WC.
    Int J Pharm; 2000 Aug 25; 204(1-2):111-6. PubMed ID: 11011993
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester.
    Larionova NI, Gladysheva IP, Polekhina OV, Kurochkina LP, Gorbatova EN.
    Appl Biochem Biotechnol; 1996 Aug 25; 61(1-2):139-48. PubMed ID: 9100351
    [Abstract] [Full Text] [Related]

  • 19. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
    St Clair WH.
    Carcinogenesis; 1991 May 25; 12(5):935-7. PubMed ID: 2029760
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.